Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001171843-13-001036)

Filing Details

Accession Number:: 0001171843-13-001036
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-18 14:13:35
Reporting Period:: 2013-03-15

Filing Date:: 2013-03-18
Accepted Time:: 2013-03-18 14:13:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1318641	Cleveland Biolabs Inc	CBLI	Services-Commercial Physical & Biological Research (8731)	200077155

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1315696	James Antal	C/O Cleveland Biolabs, Inc. 73 High Street Buffalo NY 14203		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.005 Per Share	Acquisiton	2013-03-15	3,700	$1.56	8,000	No	4	P	Indirect	Held by Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Held by Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.005 Per Share	27,258	Direct

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2011 and these shares are held by a trust of which the reporting person is a trustee.